Our research results also predicted that the high expression of lncRNA SNHG3 can be used as a biomarker of poor prognosis in patients with HCC and that SNHG3 may competitively bind multiple miRNAs to affect mRNA expression. The gene discussed is SNHG3; the disease is hepatocellular carcinoma.